🚀 RECENT AI SUCCESS
Our AI successfully predicted the gap for $PLAY and executed a BUY strategy, securing a +29.52% net profit.
UPGRADE TO SEE LIVE SIGNALS
$4151.T
Kyowa Kirin Co. Ltd.
FREE PREVIEW
📅 Next Earnings: Aug 03, 2026 🌙 Close🌐 Website🏛️ Tokyo Stock Exchange📁 Healthcare🏭 Drug Manufacturers – Specialty & Generic
AVG HISTORICAL GAP0.00%
MAX GAP RECORD0.00%
PREMIUM
AI ACCURACY RATE92.4%
Unlock AI Insights 🔓LAST 10 EARNINGS GAPS (%)
VOLATILITY & BIAS PROFILE
AVG VOLATILITY0.0%
Bullish Gaps
Bearish Gaps
Neutral
Intelligence Brief
Kyowa Kirin Co., Ltd. engages in the research, development, manufacturing, and marketing of pharmaceuticals in Japan, the Americas, Europe, Asia, and internationally. The company offers Ziftomenib, an oral menin inhibitor for the treatment of adult relapsed or refractory and acute myeloid leukemia with a nucelophosmin1 mutation; and Lumicef for the treatment of palmoplantar pustulosis. It also develops KHK4083/AMG 451 rocatinlimab,… Read full dossier
CURRENT AI SIGNAL
BULLISH STRONG
🔓 REVEAL SIGNAL